Lyme Carditis

Infectious Disease Clinics of North America

Volumn 22, Issue 2, 2008, Pages 275-288

  Fish, Airley E ^a   Pride, Yuri B ^b   Pinto, Duane S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; DOXYCYCLINE;

ANTIBIOTIC THERAPY; CARDIOVASCULAR DISEASE; CARDITIS; CLINICAL FEATURE; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INCIDENCE; LYME DISEASE; MYOCARDIAL DISEASE; NONHUMAN; POLYARTHRITIS; REVIEW; TREPONEMA PALLIDUM; VASCULITIS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LYME DISEASE; MICE; MYOCARDITIS;

EID: 42949162467     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2007.12.008     Document Type: Review

References (79)

1. Weinstein A., and Bujak D.I. Lyme disease: a review of its clinical features. N Y State J Med 89 10 (1989) 566-571
2. Steere A.C., Batsford W.P., Weinberg M., et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med 93 1 (1980) 8-16
3. Stewart A., Glass J., Patel A., et al. Lyme arthritis in the Hunter Valley. Med J Aust 1 3 (1982) 139
4. Houwerzyl J., Root J.J., and Hoogkamp-Korstanje J.A. A case of Lyme disease with cardiac involvement in the Netherlands. Infection 12 5 (1984) 358
5. Cornuau C., Bernard M., Daumas P.L., et al. Cardiac manifestations of Lyme disease. Apropos of 2 cases. Ann Cardiol Angeiol (Paris) 33 6 (1984) 395-399 [in French]
6. Steere A.C. Lyme disease. N Engl J Med 345 2 (2001) 115-125
7. Lyme disease-United States, 2003-2005. MMWR Morb Mortal Wkly Rep 56 23 (2007) 573-576
8. Lyme disease-United States, 2001-2002. MMWR Morb Mortal Wkly Rep 53 17 (2004) 365-369
9. O'Connell S., Granstrom M., Gray J.S., et al. Epidemiology of European Lyme borreliosis. Zentralbl Bakteriol 287 3 (1998) 229-240
10. Ciesielski C.A., Markowitz L.E., Horsley R., et al. Lyme disease surveillance in the United States, 1983-1986. Rev Infect Dis 11 Suppl 6 (1989) S1435-S1441
11. Schmid G.P., Horsley R., Steere A.C., et al. Surveillance of Lyme disease in the United States, 1982. J Infect Dis 151 6 (1985) 1144-1149
12. Woolf P.K., Lorsung E.M., Edwards K.S., et al. Electrocardiographic findings in children with Lyme disease. Pediatr Emerg Care 7 6 (1991) 334-336
13. Mayer W., Kleber F.X., Wilske B., et al. Persistent atrioventricular block in Lyme borreliosis. Klin Wochenschr 68 8 (1990) 431-435
14. Anderson J.F., Barthold S.W., and Magnarelli L.A. Infectious but nonpathogenic isolate of Borrelia burgdorferi. J Clin Microbiol 28 12 (1990) 2693-2699
15. Stanek G., Wewalka G., Groh V., et al. Differences between Lyme disease and European arthropod-borne Borrelia infections. Lancet 1 8425 (1985) 401
16. Hansen K., and Lebech A.M. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi-specific intrathecal antibody production. Brain 115 Pt 2 (1992) 399-423
17. Rubin D.A., Sorbera C., Nikitin P., et al. Prospective evaluation of heart block complicating early Lyme disease. Pacing Clin Electrophysiol 15 3 (1992) 252-255
18. Steere A.C. Lyme disease. N Engl J Med 321 9 (1989) 586-596
19. Vlay S.C., Dervan J.P., Elias J., et al. Ventricular tachycardia associated with Lyme carditis. Am Heart J 121 5 (1991) 1558-1560
20. de Koning J., Hoogkamp-Korstanje J.A., van der Linde M.R., et al. Demonstration of spirochetes in cardiac biopsies of patients with Lyme disease. J Infect Dis 160 1 (1989) 150-153
21. Stanek G., Klein J., Bittner R., et al. Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 322 4 (1990) 249-252
22. Duray P.H. Clinical pathologic correlations of Lyme disease. Rev Infect Dis 11 Suppl 6 (1989) S1487-S1493
23. Montgomery R.R., Booth C.J., Wang X., et al. Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis. Infect Immun 75 2 (2007) 613-620
24. Ruderman E.M., Kerr J.S., Telford III S.R., et al. Early murine Lyme carditis has a macrophage predominance and is independent of major histocompatibility complex class II-CD4+ T cell interactions. J Infect Dis 171 2 (1995) 362-370
25. Barthold S.W., Beck D.S., Hansen G.M., et al. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 162 1 (1990) 133-138
26. Cary N.R., Fox B., Wright D.J., et al. Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node. Postgrad Med J 66 772 (1990) 134-136
27. Cox J., and Krajden M. Cardiovascular manifestations of Lyme disease. Am Heart J 122 5 (1991) 1449-1455
28. Sigal L.H. Early disseminated Lyme disease: cardiac manifestations. Am J Med 98 4 (1995) 25S-28S [discussion: 28S-29S]
29. Canver C.C., Chanda J., DeBellis D.M., et al. Possible relationship between degenerative cardiac valvular pathology and Lyme disease. Ann Thorac Surg 70 1 (2000) 283-285
30. Marcus L.C., Steere A.C., Duray P.H., et al. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann Intern Med 103 3 (1985) 374-376
31. van der Linde M.R. Lyme carditis: clinical characteristics of 105 cases. Scand J Infect Dis Suppl 77 (1991) 81-84
32. Sigal L.H. Immunopathogenesis of Lyme borreliosis. Clin Dermatol 11 3 (1993) 415-422
33. Barthold S.W., Sidman C.L., and Smith A.L. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg 47 5 (1992) 605-613
34. Schaible U.E., Gay S., Museteanu C., et al. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am J Pathol 137 4 (1990) 811-820
35. Schaible U.E., Kramer M.D., Museteanu C., et al. The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis. J Exp Med 170 4 (1989) 1427-1432
36. Barthold S.W., Feng S., Bockenstedt L.K., et al. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis 25 Suppl 1 (1997) S9-S17
37. McKisic M.D., and Barthold S.W. T cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of Lyme disease. Infect Immun 68 9 (2000) 5190-5197
38. Barthold S.W., Hodzic E., Tunev S., et al. Antibody-mediated disease remission in the mouse model of Lyme borreliosis. Infect Immun 74 8 (2006) 4817-4825
39. Defosse D.L., Duray P.H., and Johnson R.C. The NIH-3 immunodeficient mouse is a model for Lyme borreliosis myositis and carditis. Am J Pathol 141 1 (1992) 3-10
40. Kelleher Doyle M., Telford III S.R., Criscione L., et al. Cytokines in murine Lyme carditis: Th1 cytokine expression follows expression of proinflammatory cytokines in a susceptible mouse strain. J Infect Dis 177 1 (1998) 242-246
41. McKisic M.D., Redmond W.L., and Barthold S.W. Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J Immunol 164 12 (2000) 6096-6099
42. Bockenstedt L.K., Kang I., Chang C., et al. CD4+ T helper 1 cells facilitate regression of murine Lyme carditis. Infect Immun 69 9 (2001) 5264-5269
43. Raveche E.S., Schutzer S.E., Fernandes H., et al. Evidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritis. J Clin Microbiol 43 2 (2005) 850-856
44. Guerau-de-Arellano M., Alroy J., and Huber B.T. Beta2 integrins control the severity of murine Lyme carditis. Infect Immun 73 6 (2005) 3242-3250
45. Saba S., VanderBrink B.A., Perides G., et al. Cardiac conduction abnormalities in a mouse model of Lyme borreliosis. J Interv Card Electrophysiol 5 2 (2001) 137-143
46. McAlister H.F., Klementowicz P.T., Andrews C., et al. Lyme carditis: an important cause of reversible heart block. Ann Intern Med 110 5 (1989) 339-345
47. Kimball S.A., Janson P.A., and LaRaia P.J. Complete heart block as the sole presentation of Lyme disease. Arch Intern Med 149 8 (1989) 1897-1898
48. Bruyn G.A., De Koning J., Reijsoo F.J., et al. Lyme pericarditis leading to tamponade. Br J Rheumatol 33 9 (1994) 862-866
49. Greenberg Y.J., Brennan J.J., and Rosenfeld L.E. Lyme myocarditis presenting as fascicular tachycardia with underlying complete heart block. J Cardiovasc Electrophysiol 8 3 (1997) 323-324
50. Seslar S.P., Berul C.I., Burklow T.R., et al. Transient prolonged corrected QT interval in Lyme disease. J Pediatr 148 5 (2006) 692-697
51. Rey M.J., Zimmermann M., Adamec R., et al. Intrahisian 2:1 atrioventricular block secondary to Lyme disease. Eur Heart J 12 9 (1991) 1048-1051
52. Rosenfeld M.E., Beckerman B., Ward M.F., et al. Lyme carditis: complete AV dissociation with episodic asystole presenting as syncope in the emergency department. J Emerg Med 17 4 (1999) 661-664
53. Artigao R., Torres G., Guerrero A., et al. Irreversible complete heart block in Lyme disease. Am J Med 90 4 (1991) 531-533
54. Nagi K.S., and Thakur R.K. Lyme carditis: indications for cardiac pacing. Can J Cardiol 11 4 (1995) 335-338
55. van der Linde M.R., Crijns H.J., de Koning J., et al. Range of atrioventricular conduction disturbances in Lyme borreliosis: a report of four cases and review of other published reports. Br Heart J 63 3 (1990) 162-168
56. Goldings E.A., and Jericho J. Lyme disease. Clin Rheum Dis 12 2 (1986) 343-367
57. Peeters AJ, Dijkmans BAC, Sedney MI. Lyme borreliosis: a hidden cause of heart block in pacemaker treated males. Presented at IV International Conference on Lyme borreliosis. Stockholm, Sweden, 1990.
58. Horowitz H.W., and Belkin R.N. Acute myopericarditis resulting from Lyme disease. Am Heart J 130 1 (1995) 176-178
59. Midttun M., Lebech A.M., Hansen K., et al. Lyme carditis: a clinical presentation and long time follow-up. Scand J Infect Dis 29 2 (1997) 153-157
60. Helmick C.G., Bernard K.W., and D'Angelo L.J. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 150 4 (1984) 480-488
61. Walker D.H., Paletta C.E., and Cain B.G. Pathogenesis of myocarditis in Rocky Mountain spotted fever. Arch Pathol Lab Med 104 4 (1980) 171-174
62. Marin-Garcia J., and Mirvis D.M. Myocardial disease in Rocky Mountain spotted fever: clinical, functional, and pathologic findings. Pediatr Cardiol 5 2 (1984) 149-154
63. Stanek G., Klein J., Bittner R., et al. Borrelia burgdorferi as an etiologic agent in chronic heart failure?. Scand J Infect Dis Suppl 77 (1991) 85-87
64. Lardieri G., Salvi A., Camerini F., et al. Isolation of Borrelia burgdorferi from myocardium. Lancet 342 8869 (1993) 490
65. Gasser R., Dusleag J., Reisinger E., et al. Reversal by ceftriaxone of dilated cardiomyopathy Borrelia burgdorferi infection. Lancet 339 8802 (1992) 1174-1175
66. Sonnesyn S.W., Diehl S.C., Johnson R.C., et al. A prospective study of the seroprevalence of Borrelia burgdorferi infection in patients with severe heart failure. Am J Cardiol 76 1 (1995) 97-100
67. Vujisic-Tesic B., Simin N., Petrovic M., et al. [The role of echocardiography in the evaluation of cardiac damage in Lyme disease]. Glas Srp Akad Nauka [Med] 43 (1993) 241-243 [in Serbian]
68. Wu L.A., Lapeyre III A.C., and Cooper L.T. Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis. Mayo Clin Proc 76 10 (2001) 1030-1038
69. Munk P.S., Orn S., and Larsen A.I. Lyme carditis: persistent local delayed enhancement by cardiac magnetic resonance imaging. Int J Cardiol 115 3 (2007) e108-e110
70. Alpert L.I., Welch P., and Fisher N. Gallium-positive Lyme disease myocarditis. Clin Nucl Med 10 9 (1985) 617
71. Jacobs J.C., Rosen J.M., and Szer I.S. Lyme myocarditis diagnosed by gallium scan. J Pediatr 105 6 (1984) 950-952
72. Reznick J.W., Braunstein D.B., Walsh R.L., et al. Lyme carditis. Electrophysiologic and histopathologic study. Am J Med 81 5 (1986) 923-927
73. Rienzo R.J., Morel D.E., Prager D., et al. Gallium avid Lyme myocarditis. Clin Nucl Med 12 6 (1987) 475-476
74. Veluvolu P., Balian A.A., Goldsmith R., et al. Lyme carditis. Evaluation by Ga-67 and MRI. Clin Nucl Med 17 10 (1992) 823
75. Sarda L., Assayag P., Palazzo E., et al. 111Indium antimyosin antibody imaging of primary myocardial involvement in systemic diseases. Ann Rheum Dis 58 2 (1999) 90-95
76. Sangha O., Phillips C.B., Fleischmann K.E., et al. Lack of cardiac manifestations among patients with previously treated Lyme disease. Ann Intern Med 128 5 (1998) 346-353
77. Olson L.J., Okafor E.C., and Clements I.P. Cardiac involvement in Lyme disease: manifestations and management. Mayo Clin Proc 61 9 (1986) 745-749
78. Sigal L.H. Current recommendations for the treatment of Lyme disease. Drugs 43 5 (1992) 683-699
79. Rahn D.W., and Malawista S.E. Lyme disease: recommendations for diagnosis and treatment. Ann Intern Med 114 6 (1991) 472-481